Tag archive

While adults who use bone conduction devices may not require auditory training, all children with hearing loss can benefit from early speech therapy and rehabilitation support. This is because, for children with hearing loss, rehabilitation involves much more than auditory training. When early detection of hearing loss is combined with early hearing device fitting and

SAMBA 2 is the latest generation audio processor for MED-EL’s active middle ear implant, VIBRANT SOUNDBRIDGE, and our bone conduction implant, BONEBRIDGE. What tests and user experiences have shown for a long time has now also been confirmed by a recent peer-reviewed publication: The sophisticated technology built into SAMBA 2 increases hearing quality and speech

BONEBRIDGE has reached an important milestone! 10 years ago, in June 2011, marked the first implantation of the one-of-a-kind BONEBRIDGE bone conduction implant by Dr. Georg Sprinzl in Innsbruck, Austria. Like Dr. Astrid Magele, Sprinzl belongs to the group of surgeons who have been part of the global BONEBRIDGE success story from the very beginning

To deter the spread of SARS-CoV-​2, or coronavirus, many governments and health authorities have called for the wearing of face masks. While the situation has recently improved and face mask requirements have eased in some countries, one thing is certain: COVID-19 has made the wearing of face masks a normal part of everyday life for billions of people, especially in clinical settings and when infection rates are high.

Today we are excited to present first-hand surgical experience on BONEBRIDGE BCI 602 from Dr. Richard Gurgel. BONEBRIDGE is our active bone conduction implant for conductive hearing loss, mixed hearing loss, and single-sided deafness. The second generation, BONEBRIDGE BCI 602, was introduced in 2019 and offers improved surgical handling, robust fixation, and the proven reliability

MED-EL is committed to providing the highest level of safety and security to our recipients, professional partners and employees. Accordingly, MED-EL rapidly established a COVID-19 response team in January 2020 and already began taking action at the beginning of February—long before many other multinational companies within the industry and over a month before the World